TRI-SCORE 與 EACTS Lead Capture 使用情況與統計
It is a simple, accurate and dedicated risk-score model to predict outcome after isolated tricuspid valve surgery for severe tricuspid regurgitation at an individual level according to the pre-operative clinical, biological and echocardiographic presentation. It has been developed from 466 consecutive adult patients who underwent an isolated tricuspid valve surgery on native valve for non- congenital severe tricuspid regurgitation at 12 tertiary French centers between January 1, 2007 and December 31, 2017. Its aim is to guide the clinical decision-making process in routine practice.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
To use this app you will need a unique activation code.
Activation codes may only be purchased by the primary contact for your organization from the EACTS Exhibition Registration area via https://membership.eacts.org/
Scanned data may only be seen and downloaded by your organization’s primary contact following each day of the event.
Please note: Do not delete the app from your device until the data has been successfully downloaded.
For more information email info@eacts.co.uk.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
TRI-SCORE與 EACTS Lead Capture 比較排名
比較過去 28 天的 TRI-SCORE 排名趨勢與 EACTS Lead Capture
排名
無可用數據
各國 TRI-SCORE vs. EACTS Lead Capture 排名比較
比較過去 28 天的 TRI-SCORE 排名趨勢與 EACTS Lead Capture
所有類別
無可用數據
醫療
使用我們的免費試用版,與所有網站進行比較
TRI-SCORE VS.
EACTS Lead Capture
12月 11, 2024